Department of Orthopaedics, Affiliated Pingyang Hospital and School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Oxid Med Cell Longev. 2022 Feb 1;2022:1337630. doi: 10.1155/2022/1337630. eCollection 2022.
Spinal cord injury (SCI), a fatal disease in the central nervous system, is characteristic of weak neuronal regeneration ability and complex pathological progress. Activation of oxidative stress (OS) and apoptosis-mediated cell death significantly contributes to the progression of SCI. Current evidence suggests that maltol exerts natural antioxidative properties via obstructing OS and apoptosis. However, the significant effect of maltol on SCI treatment has never been evaluated yet. In our current study, we explored maltol administration that could trigger the expression of Nrf2 and promote the retranslocation of Nrf2 from the cytosol to the nucleus, which can subsequently obstruct OS signal and apoptosis-mediated neuronal cell death after SCI. Furthermore, we found that maltol treatment enhances PINK1/Parkin-mediated mitophagy in PC12 cells, facilitating the recovery of mitochondrial functions. Our findings propose that maltol could be a promising therapeutic candidate for the treatment and management of SCI.
脊髓损伤(SCI)是中枢神经系统的一种致命疾病,其特征是神经元再生能力弱和病理过程复杂。氧化应激(OS)的激活和凋亡介导的细胞死亡显著促进了 SCI 的进展。目前的证据表明,麦芽酚通过阻断 OS 和凋亡发挥天然抗氧化特性。然而,麦芽酚对 SCI 治疗的显著作用尚未得到评估。在我们目前的研究中,我们探讨了麦芽酚的给药方式,它可以触发 Nrf2 的表达,并促进 Nrf2 从细胞质向核内的再移位,从而在 SCI 后阻断 OS 信号和凋亡介导的神经元细胞死亡。此外,我们发现麦芽酚处理增强了 PC12 细胞中 PINK1/Parkin 介导的线粒体自噬,促进了线粒体功能的恢复。我们的研究结果表明,麦芽酚可能是治疗和管理 SCI 的一种有前途的治疗候选药物。